Review article · 2026 · Open access

AI-integrated microfluidics for drug screening: From single cell to organ-on-a-chip

Hongyun Yin, Zheyu Li, Zinuo Shen, Shiying Wang, Na Du, Shibo Cheng, Jie Zhou, Yutao Li, Yanwei Jia, Ying Li

Acta Pharmaceutica Sinica B, 16(3), 1175–1200 · Published 8 January 2026 · DOI 10.1016/j.apsb.2026.01.001

Open full textCite this paper

In brief

“AI-integrated microfluidics for drug screening: From single cell to organ-on-a-chip” is a 2026 review article by Hongyun Yin and 9 co-authors, published in Acta Pharmaceutica Sinica B. OpenAlex counts 21 citations as of 17 November 2026, which puts it in the top 1% of works published in 2026 by citations. It is open access under a CC BY-NC-ND licence: the full text is free to read at Acta Pharmaceutica Sinica B.

Citations
21
Most cited in
2026 (21)
Field-weighted impact
9.10
References
218
Authors
10

Abstract

Drug discovery remains a protracted and capital-intensive process, primarily hindered by inefficiencies in drug screening. Microfluidic technology provides a promising approach for in vitro drug screening, enabling physiologically relevant, high-throughput, and cost-effective analysis by mimicking key aspects of cellular microenvironments. The synergistic integration of artificial intelligence (AI) with microfluidics constitutes a pivotal advancement in biomedical analysis. The convergence of the two facilitates automated data analysis, complex pattern recognition, and intelligent experimental control, thereby accelerating drug screening and contributing to enhanced precision. This review systematically presents the latest advancements in AI-assisted microfluidic drug screening, organized by increasing biological complexity: from single-cell analysis (1D), multicellular arrays (2D), and spheroids (3D), to sophisticated Organ-on-a-chip (OoC, 3D+) platforms. We detail how AI algorithms promote screening throughput, sensitivity, and physiological relevance at each scale. Furthermore, we critically discuss the prevailing challenges, including those related to data, model robustness, interpretability, and system integration. Finally, we outline future directions, highlighting the potential of AI-enhanced microfluidics to further advance precision drug discovery and biomedical research. We believe this timely review will offer a useful reference for researchers working in the interdisciplinary field of AI, microfluidics, and pharmacology. AI-assisted microfluidic platforms enable drug screening across hierarchical biological complexity, from 1D single cells and 2D multicellular arrays to 3D spheroids and Organ-on-a-chip (3D+) models.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Yin, H., Li, Z., Shen, Z., Wang, S., Du, N., Cheng, S., Zhou, J., Li, Y., Jia, Y., & Li, Y. (2026). AI-integrated microfluidics for drug screening: From single cell to organ-on-a-chip. Acta Pharmaceutica Sinica B, 16(3), 1175–1200. https://doi.org/10.1016/j.apsb.2026.01.001

MLA 9

Yin, Hongyun, et al. “AI-integrated microfluidics for drug screening: From single cell to organ-on-a-chip.” Acta Pharmaceutica Sinica B, vol. 16, no. 3, 2026, pp. 1175–1200. https://doi.org/10.1016/j.apsb.2026.01.001.

Chicago

Yin, Hongyun, Zheyu Li, Zinuo Shen, Shiying Wang, Na Du, Shibo Cheng, Jie Zhou, Yutao Li, Yanwei Jia, and Ying Li. 2026. “AI-integrated microfluidics for drug screening: From single cell to organ-on-a-chip.” Acta Pharmaceutica Sinica B 16 (3): 1175–1200. https://doi.org/10.1016/j.apsb.2026.01.001.

Harvard

Yin, H. et al. (2026) ‘AI-integrated microfluidics for drug screening: From single cell to organ-on-a-chip’, Acta Pharmaceutica Sinica B, 16(3), pp. 1175–1200. doi:10.1016/j.apsb.2026.01.001.

IEEE

H. Yin et al., “AI-integrated microfluidics for drug screening: From single cell to organ-on-a-chip,” Acta Pharmaceutica Sinica B, vol. 16, no. 3, pp. 1175–1200, 2026, doi: 10.1016/j.apsb.2026.01.001.

BibTeX

@article{yin2026integrated,
  title     = {{AI-integrated microfluidics for drug screening: From single cell to organ-on-a-chip}},
  author    = {Yin, Hongyun and Li, Zheyu and Shen, Zinuo and Wang, Shiying and Du, Na and Cheng, Shibo and Zhou, Jie and Li, Yutao and Jia, Yanwei and Li, Ying},
  journal   = {Acta Pharmaceutica Sinica B},
  year      = {2026},
  volume    = {16},
  number    = {3},
  pages     = {1175--1200},
  doi       = {10.1016/j.apsb.2026.01.001},
  url       = {https://doi.org/10.1016/j.apsb.2026.01.001}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Topic and keywords

Physical Sciences › Engineering › Biomedical Engineering › 3D Printing in Biomedical Research

  • drug screening
  • organ-on-a-chip
  • single-cell analysis
  • multicellular spheroids
  • high-throughput drug discovery
  • automated data analysis
  • model interpretability
  • in vitro model

Work with this paper

Most-cited papers in Engineering

All highly cited Engineering papers

Questions about this paper

How do I cite this paper in APA style?

Yin, H., Li, Z., Shen, Z., Wang, S., Du, N., Cheng, S., Zhou, J., Li, Y., Jia, Y., & Li, Y. (2026). AI-integrated microfluidics for drug screening: From single cell to organ-on-a-chip. Acta Pharmaceutica Sinica B, 16(3), 1175–1200. https://doi.org/10.1016/j.apsb.2026.01.001

How many times has this paper been cited?

21 times, according to OpenAlex on 17 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at Acta Pharmaceutica Sinica B: sign in and open the full text from this page.

Who wrote this paper?

Hongyun Yin, Zheyu Li, Zinuo Shen, Shiying Wang, Na Du, Shibo Cheng, Jie Zhou, Yutao Li, Yanwei Jia, Ying Li.

What is the DOI of this paper?

10.1016/j.apsb.2026.01.001, permanently at https://doi.org/10.1016/j.apsb.2026.01.001. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 17 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.